JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: SB273005 is a novel and potent integrin inhibitor with Ki of 1.2 nM and 0.3 nM for alphavbeta3 receptor and alphavbeta5 receptor, respectively. SB 273005 binds alphavbeta3 and alphavbeta5 with low nM affinity, but binds weakly to integrins alphaIIbbeta3 and alpha5beta1. SB 273005 inhibits alphavbeta3-mediated cell adhesion with an IC50 value of 3 nM, endothelial cell migration with an IC50 of 1.8 nM, and osteoclast-mediated bone resorption with an IC50 of 11 nM in vitro.
References: J Med Chem. 2000 Jan 13; 43(1):22-6; Arthritis Rheum. 2001 Jan; 44(1):128-37.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!